bluebird bio Garners $60,000,000 Series D Funding Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7b1864ce-f8cb-4712-a21c-be9ad0d564a4&Preview=1
Date 7/25/2012
Company Name bluebird bio
Mailing Address 840 Memorial Drive Cambridge, MA 02139
Company Description bluebird bio is developing innovative gene therapies for severe genetic disorders. At the heart of bluebird bio’s product creation efforts is its broadly applicable gene therapy platform for the development of novel treatments for diseases with few or no clinical options.
Proceeds Purposes Proceeds will be used to advance the company’s clinical programs in severe genetic disorders, including childhood cerebral adrenoleukodystrophy (CCALD), beta-thalassemia and sickle cell disease.